Ucephan

Active Ingredient(s): Sodium Benzoate + Sodium Phenylacetate
FDA Approved: * December 23, 1987
Pharm Company: * B BRAUN
Category: Hyperammonemia

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Ucephan Overview

.mw-parser-output .ib-chembox{border-collapse:collapse;text-align:left}.mw-parser-output .ib-chembox td,.mw-parser-output .ib-chembox th{border:1px solid #a2a9b1} Sodium benzoate Skeletal formula Ball-and-stick model of part of the crystal structure Ball-and-stick model of packing in the crystal structure Names Preferred IUPAC name Sodium benzoate Other names E211, benzoate of soda Identifiers CAS Number 532-32-1Y 3D model (JSmol) Interactive image ChEBI ...

Read more Ucephan Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Sodium_benzoate

Recent Ucephan Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Sodium Benzoate + Sodium Phenylacetate
  • Injection: 100mg/ml + 100mg/ml, 10ml + 50ml
  • Solution: 10% + 10%, 10% + 10% (5gm/50ml + 5gm/50ml), 100mg/ml + 100mg/ml
  • Solution, Solution: 300mg/10ml(30mg/ml),n/a + n/a,12.5gm/50ml(250mg/ml)
  • Tablet: 0.398gm + 1.102gm
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Drugs with one or more similar ingredients: (5 results)